ArticleMolecular cancer therapeutics2018

Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia.

Vanessa Buatois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.